Press Releases

March 5 2014

Many of the provisions included in this budget proposal would jeopardize the continued biotech...

July 10 2013

H.R. 2629 will cut compliance costs for innovative emerging biotech companies

April 8 2013

Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.

July 20 2012

New bill will update SEC filing status classifications to ease costly regulatory burdens...

March 22 2012

The Biotechnology Industry Organization (BIO) applauds the Senate on the passage of H.R. 3606...

September 16 2011

BIO President and CEO Jim Greenwood released the following statement on President Obama's...

September 1 2011

Research and development in synthetic biology is an evolution of biotechnology innovation that...

June 29 2011

“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease...

June 16 2011

The 2011 Translational Research Forum, hosted by the...

May 31 2011

BIO 2011 International Convention to feature a series of high-level panels examining...

May 26 2011

Representatives of the bioscience industry testified before the U.S. Congress Joint Economic...

May 25 2011

BIO commends Reps. Davis (D-Ca) and Schwartz (D-PA) for their continued efforts to extend the...

May 23 2011

2011 BIO International Convention will feature a series of high level panels examining the...

May 5 2011

BIO thanks Agriculture Secretary Tom Vilsack and Energy Secretary Steven Chu on the...

May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

May 4 2011

BIO announced today its selection of Senator Bob Casey (D-PA) as Legislator of the Year for...

May 4 2011

BIO announces its selection of Representative David E. Price (D-NC) as Legislator of the Year...

May 4 2011

BIO announces its selection of Michael Capuano (D-MA) as Legislator of the Year for 2010 -...

May 4 2011

BIO thanks Sen. Charles Grassley (R-Iowa) for introducing the Domestic Energy Promotion Act of...

May 3 2011

BIO along with the Juvenile Diabetes Research Foundation (JDRF) will feature a two-day...

April 28 2011

During BIO's 8th annual World Congress on Industrial Biotechnology and Bioprocessing,...

April 21 2011

Corporate leaders will discuss benefits for businesses and consumers through incorporation of...

April 14 2011

Business executives, scientists and policy makers will highlight opportunities to...

April 13 2011

Annual report prepared by UK-based PG Economics highlights agricultural biotechnology as...

April 11 2011

BIO announces that Royal DSM CEO/Chairman of the Managing Board Feike Sijbesma will be...

April 7 2011

Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating...

March 31 2011

BIO announces the industrial biotechnology companies selected to present their technology...

March 21 2011

Industry analysts are projecting double digit growth in the biobased product sector, and an...

March 16 2011

NIH Director Francis Collins, MD, PhD will share his insights on how ground-breaking biotech...

March 3 2011

The Virginia Refundable Research and Development Tax Credit, recently passed by the Virginia...

February 11 2011

According to a new survey of CEOs of small biotech firms that received Therapeutic Discovery...

January 26 2011

BIO's commends President Obama for highlighting the need to increase our nation...

September 29 2010

BIO President and CEO Jim Greenwood released the following statement on action by the U.S....

August 24 2010

BIO President and CEO Jim Greenwood issued the following statement today regarding the...

March 9 2009

BIO lauded President Barack Obama’s Executive Order to allow the National Institutes of...

June 18 2008

BIO announced today the release of a paper outlining incentives to encourage innovation for...

April 12 2007

Jim Greenwood, President and CEO of the BIO, issued the following statement on S. 5, the Stem...

July 22 1998

BIO is not surprised to learn that the Roslin Institute has verified the origins of Dolly the...

December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of implementing policies that will spur job growth through capital formation while protecting investors.  
July 28 2011
BIO submitted testimony in support of USDA research funding to the House Agriculture Subcommittee on Rural Development, Research, Biotechnology, and Foreign Agriculture. Ag research programs within the USDA have sparked agricultural innovation and will help to solve the critical food and energy security challenges facing a rapidly growing global population.
January 11 2011
Public oral comments by David Edwards (BIO) to President's Council of Advisors on Science and Technology (PCAST) regarding the need to increase funding for agricultural research in research agencies and for extramural grants.
May 27 2009
The Biotechnology Industry Organization (BIO) thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the draft guidelines for human stem cell research, published in the Federal Register on April 23, 2009...
June 6 2007
As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s support for S. 5, the Stem Cell Research Enhancement Act...
March 25 2014
Principles reaffirm and broaden biotech industry’s commitment to transparency, advancing research
March 5 2014
Many of the provisions included in this budget proposal would jeopardize the continued biotech research and development that is necessary to find cures and breakthrough medicines for patients living with debilitating and life-threatening diseases. 
July 10 2013
H.R. 2629 will cut compliance costs for innovative emerging biotech companies
April 8 2013
Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.
July 20 2012
New bill will update SEC filing status classifications to ease costly regulatory burdens on small public companies